User profiles for Gwenael Le Teuff

Gwénaël Le Teuff

Gustave Roussy
Verified email at gustaveroussy.fr
Cited by 5145

Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung …

…, L Seymour, A Bourredjem, GL Teuff… - Journal of clinical …, 2013 - ascopubs.org
Purpose We undertook this analysis of KRAS mutation in four trials of adjuvant chemotherapy
(ACT) versus observation (OBS) to clarify the prognostic/predictive roles of KRAS in non–…

Screening for SARS-CoV-2 by RT-PCR: Saliva or nasopharyngeal swab? Rapid review and meta-analysis

N Ibrahimi, A Delaunay-Moisan, C Hill, G Le Teuff… - PLoS …, 2021 - journals.plos.org
Background Diagnosis of COVID-19 in symptomatic patients and screening of populations
for SARS-CoV-2 infection require access to straightforward, low-cost and high-throughput …

[HTML][HTML] ERCC1 isoform expression and DNA repair in non–small-cell lung cancer

…, A Dunant, V Rousseau, G Le Teuff… - … England Journal of …, 2013 - Mass Medical Soc
Background The excision repair cross-complementation group 1 (ERCC1) protein is a
potential prognostic biomarker of the efficacy of cisplatin-based chemotherapy in non–small-cell …

[HTML][HTML] Prognostic effect of tumor lymphocytic infiltration in resectable non–small-cell lung cancer

E Brambilla, G Le Teuff, S Marguet… - Journal of clinical …, 2016 - ncbi.nlm.nih.gov
… Collection and assembly of data: Elisabeth Brambilla, Gwénaël Le Teuff, Sylvie
Lantuejoul, Ariane Dunant, Stephen Graziano, Robert Kratzke, Helmut Popper, Lesley …

[HTML][HTML] Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection

MS Tsao, S Marguet, G Le Teuff… - Journal of clinical …, 2015 - ncbi.nlm.nih.gov
Purpose The classification for invasive lung adenocarcinoma by the International Association
for the Study of Lung Cancer, American Thoracic Society, European Respiratory Society, …

[HTML][HTML] Tumor mutation burden as a biomarker in resected non–small-cell lung cancer

…, A McLeer-Florin, K Ding, G Le Teuff… - Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
Purpose The survival benefit with adjuvant chemotherapy for patients with resected stage II-III
non–small-cell lung cancer (NSCLC) is modest. Efforts to develop prognostic or predictive …

Bayesian survival analysis in clinical trials: What methods are used in practice?

C Brard, G Le Teuff, MC Le Deley… - Clinical Trials, 2017 - journals.sagepub.com
Background Bayesian statistics are an appealing alternative to the traditional frequentist
approach to designing, analysing, and reporting of clinical trials, especially in rare diseases. …

[PDF][PDF] Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro …

…, I Lewis, B Brennan, A Ranft, J Whelan, G Le Teuff… - J Clin Oncol, 2014 - academia.edu
Purpose Relative efficacy and toxicity of cyclophosphamide compared with ifosfamide are
debatable. The Euro-EWING99-R1 trial asked whether cyclophosphamide may replace …

High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-EWING …

…, MC Le Deley, U Dirksen, G Le Teuff… - Journal of Clinical …, 2018 - ascopubs.org
Purpose For over 30 years, the place of consolidation high-dose chemotherapy in Ewing
sarcoma (ES) has been controversial. A randomized study was conducted to determine …

High-dose chemotherapy compared with standard chemotherapy and lung radiation in Ewing sarcoma with pulmonary metastases: results of the European Ewing …

…, RL Randall, A Ranft, G Le Teuff… - Journal of clinical …, 2019 - ascopubs.org
PURPOSE The R2Pulm trial was conducted to evaluate the effect of busulfan-melphalan
high-dose chemotherapy with autologous stem-cell rescue (BuMel) without whole-lung …